A post-marketing surveillance study* has revealed no new evidence to suggest that the new measles mumps and rubella virus (MMR) vaccine [Priorix]

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2007年 / 1150卷 / 1期
关键词：
Public Health; Meningitis; Measle; Absolute Risk; Rubella;
D O I：
10.1007/BF03272442
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 15 条
  • [1] Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017
    Stefanizzi, Pasquale
    De Nitto, Sara
    Patano, Francesco
    Bianchi, Francesco Paolo
    Ferorelli, Davide
    Stella, Paolo
    Ancona, Domenica
    Bavaro, Vito
    Tafuri, Silvio
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (08) : 1875 - 1883
  • [2] A new US Centers for Disease Control and Prevention (CDC) study* found no link between the measles-mumps-rubella (MMR) vaccine and autism
    [J]. Reactions Weekly, 2008, 1219 (1) : 4 - 4
  • [3] FIELD TRIAL WITH A LIVE MEASLES-MUMPS-RUBELLA VACCINE - SUCCESSFUL USE OF A NEW COMBINATION OF VIRUS STRAINS
    WALTERS, VW
    MILLER, SA
    JACKSON, JE
    KENNY, MT
    [J]. CLINICAL PEDIATRICS, 1975, 14 (10) : 928 - 933
  • [4] Reactogenicity and immunogicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children
    Kanra, G
    Ceyhan, M
    Özmert, E
    [J]. TURKISH JOURNAL OF PEDIATRICS, 2000, 42 (04) : 275 - 277
  • [5] CLINICAL EVALUATION OF A NEW MEASLES-MUMPS-RUBELLA COMBINED LIVE VIRUS-VACCINE IN DOMINICAN-REPUBLIC
    EHRENKRANZ, NJ
    VENTURA, AK
    MEDLER, EM
    JACKSON, JE
    KENNY, MT
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1975, 52 (01) : 81 - 85
  • [6] Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
    Huang, Li-Min
    Lin, Tzou-Yien
    Chiu, Cheng-Hsun
    Chiu, Nan-Chang
    Chen, Po-Yen
    Yeh, Shu-Jen
    Boaz, Mark
    Hutagalung, Yanee
    Bouckenooghe, Alain
    Feroldi, Emmanuel
    [J]. VACCINE, 2014, 32 (41) : 5363 - 5369
  • [7] Post-Marketing Surveillance of the Adverse Events Following Immunization with a New Pentavalent Vaccine (DPT-HB plus Hib)
    Muzio, V.
    Aguilar, A.
    Veliz, G.
    Figueroa, N.
    Diaz, P. A.
    Perez, K.
    Mataran, M.
    Vazquez, M. M.
    Quintana-Vazquez, D.
    Guillen, G.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E143 - E143
  • [8] Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance
    Pavlova, BG
    Loew-Baselli, A
    Fritsch, S
    Poellabauer, EM
    Vartian, N
    Rinke, I
    Ehrlich, HJ
    [J]. VACCINE, 2003, 21 (7-8) : 742 - 745
  • [9] A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac®) in India
    Kulkarni, Prasad S.
    Raut, Sidram K.
    Dhere, Rajeev M.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (01) : 122 - 124
  • [10] Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial
    Nakayama, Tetsuo
    Eda, Masahiro
    Hirano, Motonori
    Goto, Wakako
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1139 - 1144
12